SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,147.00    10.50 (0.92%)
Bid:
1,144.00
Ask:
1,145.00
Spread: 1.00 (0.087%)
Market Cap: £6.89b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Second/Further Notice - Guaranteed Notes

14 Dec 2022 14:52

RNS Number : 7377J
Pearson PLC
14 December 2022
Β 

Pearson plcDecember 14, 2022

NOTICE IN RESPECT OF THE$500,000,000 3.250% GUARANTEED NOTES DUE 2023 (THE "NOTES") (OF WHICH $94,176,000 IN PRINCIPAL AMOUNT ARE OUTSTANDING)

Rule 144A Notes:Cusip No.: 70501VAA6, ISIN: 1 US70501VAA61, Common Code: 092818845

Regulation S Notes:

Cusip No.: G6964RAA2 ISIN: USG6964RAA26, Common Code: 092818861

OF

PEARSON FUNDING PLC (THE "ISSUER")

GUARANTEED BY PEARSON PLC

Notice was given on November 15, 2022 (the "First Notice") that, pursuant to Section 6.2 of the Indenture, dated as of May 8, 2013 (the "Indenture"), by and among Pearson Funding plc, a public limited company incorporated under the laws of England and Wales (the "Company"), Pearson plc, as guarantor, and The Bank of New York Mellon, as Trustee, Paying Agent and Calculation Agent (the "Trustee") the Company's 3.250% Guaranteed Notes due 2023 (the "Notes"), of which $94,176,000 in principal amount are outstanding, will be redeemed by the Issuer in whole at a redemption price equal to (a) any accrued and unpaid interest to (but excluding) December 16, 2022 (the "Redemption Date") and Additional Amounts (as defined in the Indenture), if any, plus (b) the greater of (i) 100% of the principal amount of the notes to be redeemed and (ii) as determined by The Bank of New York Mellon, as Calculation Agent, the sum of the present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed, not including any portion of such payment of interest accrued on the Redemption Date, from the Redemption Date to the maturity date, May 8, 2023, discounted to the Redemption Date on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate (as defined in the Indenture), plus 25 basis points (the "Redemption Price").

Unless otherwise defined in this notice, all words and expressions defined in the Indenture and the First Notice shall have the same meaning in this notice.

NOTICE IS HEREBY GIVEN THAT, for purposes of calculating the Redemption Price, the Treasury Rate shall be determined by reference to the following Comparable Treasury Issue: 1% Treasury securities maturing on 05/15/2023 - CUSIP 912828VB3.

The Redemption Price will be calculated on December 15, 2022, and payment of the Redemption Price will be made on the Redemption Date. Any interest thereon, if any, shall cease to accrue on and after such date.

For further information, please contact:

Trustee, Paying Agent and Calculation Agent:

The Bank of New York MellonOne Canada SquareLondon E14 5AL

Issuer:

Pearson Funding plc80 StrandLondon WC2R 0RL

Guarantor:

Pearson plc80 StrandLondon WC2R 0RL

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCUSVSRURUUAAA
Date   Source Headline
28th Jul 20239:31 amRNSCommittee Changes
27th Jul 20239:48 amRNSDirector Declaration
19th Jul 20234:13 pmRNSDirector/PDMR Shareholding
4th Jul 20239:10 amRNSDirector/PDMR Shareholding
3rd Jul 20233:38 pmRNSTotal Voting Rights
14th Jun 20235:17 pmRNSHolding(s) in Company
1st Jun 202312:32 pmRNSBlock listing Interim Review
1st Jun 202312:28 pmRNSTotal Voting Rights
26th May 20234:48 pmRNSHolding(s) in Company
19th May 20233:00 pmRNSDirector/PDMR Shareholding
17th May 20234:50 pmRNSDirector/PDMR Shareholding
16th May 20234:16 pmRNSDirector/PDMR Shareholding
10th May 20234:30 pmRNSDirector/PDMR Shareholding
10th May 202310:49 amRNSDirectorate Change
9th May 20234:15 pmRNSHolding(s) in Company
9th May 20239:00 amRNSPearson: Generative AI Strategy Update
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
4th May 20234:30 pmRNSDirector/PDMR Shareholding
3rd May 20234:13 pmRNSHolding(s) in Company
2nd May 20233:57 pmRNSTotal Voting Rights
28th Apr 20231:11 pmRNSResult of AGM
28th Apr 20237:00 amRNSPearson 2023 Q1 Trading Update
20th Apr 20234:19 pmRNSHolding(s) in Company
11th Apr 20239:17 amRNSHolding(s) in Company
4th Apr 20234:30 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSHolding(s) in Company
4th Apr 20237:00 amRNSDirector/PDMR Shareholding
3rd Apr 20233:00 pmRNSTotal Voting Rights
31st Mar 20233:44 pmRNSForm 20-F for the year ended 31 December 2022
31st Mar 20232:29 pmRNSHolding(s) in Company
28th Mar 202311:17 amRNSDirector Declaration
27th Mar 20234:05 pmRNSHolding(s) in Company
24th Mar 202312:30 pmRNSNotice of AGM
23rd Mar 20237:00 amRNSPearson Completes Acquisition of PDRI
21st Mar 20237:00 amRNSPearson to sell POLS
16th Mar 20233:09 pmRNSAnnual Financial Report
16th Mar 202311:28 amRNSDirector Declaration
7th Mar 20234:36 pmRNSDirector/PDMR Shareholding
3rd Mar 20237:00 amRNSPearson 2022 Preliminary Results
2nd Mar 20233:37 pmRNSCommittee Change
1st Mar 202310:10 amRNSTotal Voting Rights
8th Feb 20232:37 pmRNSHolding(s) in Company
3rd Feb 20234:23 pmRNSDirector/PDMR Shareholding
1st Feb 202311:10 amRNSTotal Voting Rights
18th Jan 20237:00 amRNSPearson 2022 Trading Update
4th Jan 20233:04 pmRNSDirector/PDMR Shareholding
3rd Jan 20239:25 amRNSTotal Voting Rights
19th Dec 202212:02 pmRNSDirector/PDMR Shareholding
19th Dec 202212:00 pmRNSPearson to Acquire PDRI

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.